CURX
Curanex Pharmaceuticals Inc Common Stock
NASDAQ: CURX · HEALTHCARE · BIOTECHNOLOGY
$0.33
-8.73% today
Updated 2026-06-05
Market cap
$8.59M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-0.02
Dividend yield
—
52W range
$0 – $9
Volume
0.1M
WallStSmart proprietary scores
23
out of 100
Grade: F
Strong Sell
Investment rating
4.3
Growth
C7.8
Quality
B+3.0
Profitability
D5.0
Valuation
C+4/9
Piotroski F-Score
Moderate
—
Altman Z-Score
—
—
Industry rank
—
View all highly rated stocks (75+) →202 stocks currently score above 75
Price targets
Analyst target
—
—
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
Price chart
Stock snapshot
Strengths
+ Debt/equity 0.04x — low leverage
Risks
- Thin margins at 0.00%
- Negative free cash flow $-954560.00
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $26000.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net income | $-20233.00 | $-19198.00 | $-361506.00 | $-4.23M | $-3.15M |
| EPS | — | — | — | — | $-0.02 |
| Free cash flow | $3336.00 | $-120.00 | $-555580.00 | $-10.48M | $-954560.00 |
| Profit margin | -77.82% | — | — | — | — |
Peer comparison
Smart narrative
Curanex Pharmaceuticals Inc Common Stock trades at $0.33. Our Smart Value Score of 23/100 indicates the stock is weak. The company scores 4/9 on the Piotroski F-Score.
Frequently asked questions
What is Curanex Pharmaceuticals Inc Common Stock's stock price?
Curanex Pharmaceuticals Inc Common Stock (CURX) trades at $0.33.
Is Curanex Pharmaceuticals Inc Common Stock overvalued?
Curanex Pharmaceuticals Inc Common Stock carries a Smart Value Score of 23/100 (Grade F), which we rate Strong Sell. That score blends growth, quality, and valuation into one read.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio—
ROE-89.59%
Beta—
50D MA$0.40
200D MA$0.97
Shares out0.03B
Float0.01B
Short ratio—
Avg volume0.1M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—